Recent Events & Catalysts

Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer

Yahoo · today

Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate

Yahoo · today

DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?

Yahoo · today

Guggenheim Maintains Buy on Neurocrine Biosciences, Raises Price Target to $200

Benzinga · today

ZNTL Stock Rises 28% in 3 Months: What's Driving the Rally?

Yahoo · 1d ago

Neurocrine Biosciences (NASDAQ:NBIX) Offers a High Growth Momentum Breakout Setup

ChartMill · 1d ago

Profitable Biotechs Strut Their Stuff As Stock Market Stumbles

Yahoo · 4d ago

Wells Fargo Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $200

Benzinga · 4d ago

Departure/appointment of directors or officers, Submission of matters to a vote of security holders

Filed 2026-05-28 · 54d ago

Entry into a material agreement, Completion of acquisition or disposition of assets, Creation of a direct financial obligation (new debt), Regulation FD disclosure, Financial statements and exhibits

Filed 2026-05-18 · 64d ago · Material

Results of operations (earnings release), Financial statements and exhibits

Filed 2026-05-05 · 77d ago · Material